
    
      This is a multicenter, open-label, randomized, clinical trial to assess the efficacy and
      safety of Levopront® syrup 30 mg/5 ml in comparison with Libexin® 100 mg tablets in patients
      suffering from dry non-productive cough caused by acute upper respiratory infection
    
  